Palantir (PLTR) Stock at $196 After a 2.7% Drop:…
Updated 23 October 2026. Palantir (PLTR) closed at $196.19 on Thursday 22 October, down $5.53 or 2.74 percent, giving back most of Wednesday's 4.74...
Why Is Moderna Stock Down 18%? Cancer Vaccine Leak
Moderna stock is down because investors sold a Phase 3 melanoma result they had already paid for, after the number leaked two days early...
Kospi Reverses 3.29% Rally as Lam Research Slides 6%
South Korea’s Kospi gave back much of Wednesday’s rebound on Thursday, closing down 201.89 points, or 3.52%, at 5,533.77. Samsung Electronics fell 4.02% and...
CrowdStrike stock prediction: $439.39 bull, $216.93 bear
CrowdStrike is not being rerated by a Wednesday headline. The Nasdaq official close on 21 October 2026 was $239.34, up $11.97, or 5.26 percent,...
Elon Musk Net Worth Today: $989 Billion on Forbes as SpaceX…
Updated 22 October 2026. Forbes' real-time profile puts Elon Musk's net worth at $989 billion on Thursday 22 October, up $64 billion or 6.92...
Palantir (PLTR) Stock Today: Bull and Bear Case as Citi…
Updated 22 October 2026. Palantir (PLTR) closed at $201.72 on Wednesday 21 October, up $9.12 or 4.74 percent, its first close above $200 since...
Nasdaq 100 swings as strong tech earnings meet rising rate…
The Nasdaq 100 (USTEC) is being pulled in two directions. Higher energy prices, linked to the situation in the Middle East, are keeping US...
SpaceX revenue up 161% to $14.6 billion
SpaceX did not just report a Starlink quarter. Space Exploration Technologies posted revenue of $14.6 billion for the three months ended 30 September 2026,...
Micron stock prediction: $1,464.63 bull, $585.63 bear
The myth is that Tuesday's Micron close still prices the $61.5 billion fiscal first-quarter guide. It does not. Micron Technology closed Tuesday 20 October...
INmune Bio Signs Uniphar Deal to Build Global Access Route…
Key Facts
INmune Bio (NASDAQ: INMB) has signed a Master Services Agreement with Uniphar Durbin Ireland Limited covering international access, distribution and commercialisation of...

















